<code id='E8F05D45A0'></code><style id='E8F05D45A0'></style>
    • <acronym id='E8F05D45A0'></acronym>
      <center id='E8F05D45A0'><center id='E8F05D45A0'><tfoot id='E8F05D45A0'></tfoot></center><abbr id='E8F05D45A0'><dir id='E8F05D45A0'><tfoot id='E8F05D45A0'></tfoot><noframes id='E8F05D45A0'>

    • <optgroup id='E8F05D45A0'><strike id='E8F05D45A0'><sup id='E8F05D45A0'></sup></strike><code id='E8F05D45A0'></code></optgroup>
        1. <b id='E8F05D45A0'><label id='E8F05D45A0'><select id='E8F05D45A0'><dt id='E8F05D45A0'><span id='E8F05D45A0'></span></dt></select></label></b><u id='E8F05D45A0'></u>
          <i id='E8F05D45A0'><strike id='E8F05D45A0'><tt id='E8F05D45A0'><pre id='E8F05D45A0'></pre></tt></strike></i>

          Home / comprehensive / leisure time

          leisure time


          leisure time

          author:fashion    Page View:58
          Adam's take main illustration
          Molly Ferguson/STAT

          Biotech is awash in PIPEs.

          The numbers behind these privately negotiated purchases of public-company stock are astounding. By my count, there have been 30 PIPE transactions involving public biotechs and institutional investors (mostly hedge funds) that have raised $4 billion in the first two months of the year.

          advertisement

          Just this week, five biotechs have brought in a combined $950 million via PIPEs, including Denali Therapeutics raising $500 million, the largest such financing this year. Crinetics Pharmaceuticals raised $350 million.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In